BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
BioAtla, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.31−0.05 (-3.68%)
Close on Oct 19, 2026
- Market cap
- $2.18M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
11.2%
0M of 2M shares
Institutional holders
20
19 new, 1 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Highbridge Capital Management, LLC | 4,839,579 | 7.70% | 13G (passive) amendment | Mar 31, 2025 |
| Anders Hove | 4,835,111 | 8.30% | 13G (passive) amendment | May 15, 2025 |
| Jay M. Short | 3,865,646 | 6.60% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BCAB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Millennium Management LLC | 70,616 | 4.24% | $292.35K | New | 0.00% |
| Lido Advisors, LLC | 16,656 | 1.00% | $68.96K | New | 0.00% |
| Stonepine Capital Management, LLC | 16,432 | 0.99% | $68.03K | New | 0.04% |
| Acadian Asset Management LLC | 14,294 | 0.86% | $58 | New | 0.00% |
| Hrt Financial LP | 13,276 | 0.80% | $54 | New | 0.00% |
| Geode Capital Management, LLC | 12,819 | 0.77% | $53.08K | New | 0.00% |
| Deutsche Bank AG\ | 10,556 | 0.63% | $43.70K | New | 0.00% |
| BlackRock, Inc. | 9,616 | 0.58% | $39.81K | New | 0.00% |
| Vanguard Capital Management LLC | 9,164 | 0.55% | $37.94K | New | 0.00% |
| UBS Group AG | 6,201 | 0.37% | $25.67K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 4,730 | 0.28% | $19.58K | New | 0.00% |
| Morgan Stanley | 1,108 | 0.07% | $4.59K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 863 | 0.05% | $3.57K | New | 0.00% |
| Forum Finance Group S.A. | 400 | 0.02% | $1 | New | 0.00% |
| SBI Securities Co., Ltd. | 267 | 0.02% | $1.11K | +45 | 0.00% |
| Twin Lakes Capital Management, LLC | 144 | 0.01% | $596 | New | 0.00% |
| JPMorgan Chase & Co | 121 | 0.01% | $464 | New | 0.00% |
| Barclays PLC | 101 | 0.01% | $418 | New | 0.00% |
| Jones Financial Companies Lllp | 40 | 0.00% | $147 | New | 0.00% |
| Bnp Paribas Arbitrage, Snc | 7 | 0.00% | $29 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 20 | 0M | 11.2% | 19 / 1 | 0 / 1 | 0M | 0M |
| Q1 2026 | 2 | 0M | 0.3% | 2 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of BCAB | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 9,164 | 0.55% | $37.94K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 6,128 | 0.37% | $24.08K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 1,610 | 0.10% | $6.33K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 1,456 | 0.09% | $5.72K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 165 | 0.01% | $648 | 0.00% | May 31, 2026 |
| State Street Balanced Index Fund | 25 | 0.00% | $104 | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -36 | -0.00% | -$149 | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jay M. Short Phd | Chief Executive Officer, Director | 84,300 | 5.06% | Sep 2, 2026 |
| Eric Sievers | Chief Medical Officer | 11,346 | 0.68% | Sep 2, 2026 |
| Christian Vasquez | Chief Financial Officer | 10,476 | 0.63% | Sep 2, 2026 |
| Richard A. Waldron | Former Chief Financial Officer | 343,421 | 20.61% | Mar 2, 2026 |
| Eddie Williams | Director | 60,200 | 3.61% | Jun 18, 2025 |
| Mary Ann Gray | Director | 77,397 | 4.65% | Jun 18, 2025 |
| Scott Andrew Smith | Director | 321,550 | 19.30% | Jun 18, 2025 |
| Susan Moran | Director | 52,307 | 3.14% | Jun 18, 2025 |
| Lawrence Steinman | Director | 78,459 | 4.71% | Jun 18, 2025 |
| Sylvia McBrinn | Director | 59,125 | 3.55% | Jun 18, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jay M. Short Phd Chief Executive Officer, Director | Aug 31, 2026 | Tax withholding | −259 | $1.69 | $438 | 52,035 |
| Christian Vasquez Chief Financial Officer | Aug 31, 2026 | Tax withholding | −71 | $1.69 | $120 | 10,476 |
| Eric Sievers Chief Medical Officer | Aug 31, 2026 | Tax withholding | −134 | $1.69 | $226 | 11,346 |
| Eric Sievers Chief Medical Officer | May 31, 2026 | Tax withholding | −134 | $3.93 | $527 | 11,840 |
| Jay M. Short Phd Chief Executive Officer, Director | May 31, 2026 | Tax withholding | −259 | $3.93 | $1.02K | 52,294 |
| Christian Vasquez Chief Financial Officer | May 31, 2026 | Tax withholding | −82 | $3.93 | $322 | 10,347 |
| Jay M. Short Phd Chief Executive Officer, Director | Mar 12, 2026 | Tax withholding | −639 | $0.17 | $109 | 52,553 |
| Eric Sievers Chief Medical Officer | Mar 11, 2026 | Tax withholding | −360 | $0.17 | $61 | 11,614 |
| Christian Vasquez Chief Financial Officer | Mar 11, 2026 | Tax withholding | −175 | $0.17 | $30 | 10,429 |
| Jay M. Short Phd Chief Executive Officer, Director | Mar 11, 2026 | Award | +430,000 | – | – | 2,659,603 |
| Christian Vasquez Chief Financial Officer | Mar 10, 2026 | Award | +240,000 | – | – | 530,196 |
| Eric Sievers Chief Medical Officer | Mar 10, 2026 | Award | +240,000 | – | – | 598,705 |
| Jay M. Short Phd Chief Executive Officer, Director | Feb 28, 2026 | Tax withholding | −7,728 | $0.25 | $1.93K | 2,229,603 |
| Richard A. Waldron Former Chief Financial Officer | Feb 28, 2026 | Tax withholding | −2,729 | $0.25 | $682 | 343,421 |
| Eric Sievers Chief Medical Officer | Feb 28, 2026 | Tax withholding | −3,140 | $0.25 | $785 | 358,705 |
| Christian Vasquez Chief Financial Officer | Feb 28, 2026 | Tax withholding | −1,802 | $0.25 | $451 | 290,196 |
| Jay M. Short Phd Chief Executive Officer, Director, 10% owner | Nov 30, 2025 | Tax withholding | −6,347 | $0.90 | $5.71K | 2,237,331 |
| Eric Sievers Chief Medical Officer | Nov 30, 2025 | Tax withholding | −2,729 | $0.90 | $2.46K | 361,845 |
| Richard A. Waldron Chief Financial Officer | Nov 30, 2025 | Tax withholding | −2,371 | $0.90 | $2.13K | 346,150 |
| Christian Vasquez See Remarks | Nov 30, 2025 | Tax withholding | −1,566 | $0.90 | $1.41K | 291,998 |
| Christian Vasquez See Remarks | Aug 31, 2025 | Tax withholding | −1,566 | $0.46 | $720 | 283,564 |
| Jay M. Short Phd Chief Executive Officer, Director, 10% owner | Aug 31, 2025 | Tax withholding | −6,347 | $0.46 | $2.92K | 2,243,678 |
| Eric Sievers Chief Medical Officer | Aug 31, 2025 | Tax withholding | −2,729 | $0.46 | $1.26K | 364,574 |
| Richard A. Waldron Chief Financial Officer | Aug 31, 2025 | Tax withholding | −2,371 | $0.46 | $1.09K | 338,521 |
| Eddie Williams Director | Jun 18, 2025 | Award | +23,500 | – | – | 60,200 |
| Susan Moran Director | Jun 18, 2025 | Award | +23,500 | – | – | 52,307 |
| Scott Andrew Smith Director | Jun 18, 2025 | Award | +23,500 | – | – | 321,550 |
| Sylvia McBrinn Director | Jun 18, 2025 | Award | +23,500 | – | – | 59,125 |
| Lawrence Steinman Director | Jun 18, 2025 | Award | +23,500 | – | – | 78,459 |
| Mary Ann Gray Director | Jun 18, 2025 | Award | +23,500 | – | – | 77,397 |
| Eric Sievers Chief Medical Officer | May 31, 2025 | Tax withholding | −2,729 | $0.41 | $1.12K | 367,303 |
| Richard A. Waldron Chief Financial Officer | May 31, 2025 | Tax withholding | −2,371 | $0.41 | $972 | 340,892 |
| Jay M. Short Phd Chief Executive Officer, Director, 10% owner | May 31, 2025 | Tax withholding | −6,347 | $0.41 | $2.60K | 2,250,025 |
| Christian Vasquez See Remarks | May 31, 2025 | Tax withholding | −1,566 | $0.41 | $642 | 285,130 |
| Jay M. Short Phd Chief Executive Officer, Director, 10% owner | Mar 12, 2025 | Award | +431,000 | – | – | 2,256,372 |
| Eric Sievers Chief Medical Officer | Mar 11, 2025 | Award | +175,000 | – | – | 370,032 |
| Christian Vasquez See Remarks | Mar 11, 2025 | Award | +85,000 | – | – | 276,696 |
| Richard A. Waldron Chief Financial Officer | Mar 11, 2025 | Award | +100,000 | – | – | 333,263 |
| Jay M. Short Phd Chief Executive Officer, Director, 10% owner | Feb 16, 2025 | Tax withholding | −30,911 | $0.46 | $14.22K | 1,825,372 |
| Christian Vasquez See Remarks | Feb 15, 2025 | Tax withholding | −7,189 | $0.46 | $3.31K | 191,696 |
| Eric Sievers Chief Medical Officer | Feb 15, 2025 | Tax withholding | −12,530 | $0.46 | $5.76K | 195,032 |
| Richard A. Waldron Chief Financial Officer | Feb 15, 2025 | Tax withholding | −10,887 | $0.46 | $5.01K | 233,263 |
| Scott Andrew Smith Director | Aug 31, 2024 | Tax withholding | −2,181 | $1.77 | $3.86K | 298,050 |
| Eric Sievers Chief Medical Officer | Aug 31, 2024 | Tax withholding | −572 | $1.77 | $1.01K | 207,562 |
| Eric Sievers Chief Medical Officer | Jul 31, 2024 | Tax withholding | −572 | $1.81 | $1.04K | 208,134 |
| Scott Andrew Smith Director | Jul 31, 2024 | Tax withholding | −2,181 | $1.81 | $3.95K | 300,231 |
| Scott Andrew Smith Director | Jun 30, 2024 | Tax withholding | −2,181 | $1.37 | $2.99K | 302,412 |
| Eric Sievers Chief Medical Officer | Jun 30, 2024 | Tax withholding | −572 | $1.37 | $784 | 208,706 |
| Susan Moran Director | Jun 13, 2024 | Award | +16,500 | – | – | 28,807 |
| Lawrence Steinman Director | Jun 13, 2024 | Award | +16,500 | – | – | 54,959 |
| Scott Andrew Smith Director | Jun 13, 2024 | Award | +16,500 | – | – | 304,593 |
| Eddie Williams Director | Jun 13, 2024 | Award | +16,500 | – | – | 36,700 |
| Mary Ann Gray Director | Jun 13, 2024 | Award | +16,500 | – | – | 53,897 |
| Sylvia McBrinn Director | Jun 13, 2024 | Award | +16,500 | – | – | 35,625 |
| Scott Andrew Smith Director | May 31, 2024 | Tax withholding | −2,181 | $1.51 | $3.29K | 288,093 |
| Eric Sievers Chief Medical Officer | May 31, 2024 | Tax withholding | −572 | $1.51 | $864 | 209,278 |
| Scott Andrew Smith Director | Apr 30, 2024 | Tax withholding | −2,181 | $2.26 | $4.93K | 290,274 |
| Eric Sievers Chief Medical Officer | Apr 30, 2024 | Tax withholding | −572 | $2.26 | $1.29K | 209,850 |
| Scott Andrew Smith Director | Mar 31, 2024 | Tax withholding | −2,181 | $3.44 | $7.50K | 292,455 |
| Eric Sievers Chief Medical Officer | Mar 31, 2024 | Tax withholding | −572 | $3.44 | $1.97K | 210,422 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.